UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Earliest Event Reported) November 8, 2017
 
CYTRX CORPORATION
(Exact Name of Registrant as Specified in its Charter)
 
Delaware
(State or Other Jurisdiction of Incorporation)
 
000-15327
(Commission File Number)
58-1642740
(I.R.S. Employer Identification No.)
 
 
11726 San Vicente Boulevard, Suite 650
Los Angeles, California
(Address of Principal Executive Offices)
 
90049
(Zip Code)
 
(310) 826-5648
(Registrant's Telephone Number, Including Area Code)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).  Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 


 
  Item 2.02.   Results of Operations and Financial Condition.
      On November 8, 2017, CytRx Corporation (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2017 and discussing recent accomplishments and plans.  
      In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

Item 9.01.  Financial Statements and Exhibits.
(d)  Exhibits.
Exhibit No.
 
Description
 
Press Release dated November 8, 2017
 





SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  CYTRX CORPORATION  
       
Date: November 9, 2017
By:
/s/ JOHN Y. CALOZ  
    John Y. Caloz  
    Title: Chief Financial Officer  
       
Cytrx (NASDAQ:CYTR)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Cytrx Charts.
Cytrx (NASDAQ:CYTR)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Cytrx Charts.